MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
SYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Spyre Therapeutics (SYRE) Earnings Date & Reports

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection... Show more

A.I. Advisor
published Earnings

SYRE is expected to report earnings to rise 64.39% to -80 cents per share on November 06

Spyre Therapeutics SYRE Stock Earnings Reports
Q3'25
Est.
$-0.81
Q2'25
Beat
by $0.26
Q1'25
Beat
by $0.24
Q4'24
Beat
by $0.22
Q3'24
Missed
by $0.54
The last earnings report on August 05 showed earnings per share of -49 cents, beating the estimate of -75 cents. With 417.79K shares outstanding, the current market capitalization sits at 915.68M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SYRE
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For SYRE
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SYRE showed earnings on August 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com